Skip to main content
OpenTrials

Clinical trial condition

Adenoma, Islet Cell

Explore clinical trials studying Adenoma, Islet Cell. Study availability and eligibility vary by location and protocol.

81 public trials 26 recruiting studies
Refine in advanced search Browse all conditions

Adenoma, Islet Cell trial results

Recruiting

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

NCT06943755

Conditions
Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +19 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • Cedars-Sinai Medical Center Beverly Hills, California, United States
View all 117 locations
View Trial Details
Recruiting

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

NCT04924075

Conditions
Abnormalities, Multiple, Adenoma, Adenoma, Islet Cell, +31 more
Locations
  • Cedars-Sinai Medical Center ( Site 0110) Los Angeles, California, United States
  • Northwestern University - Robert H. Lurie Comprehensive Cancer Center ( Site 0130) Chicago, Illinois, United States
  • Northwestern Medicine Cancer Center - Warrenville ( Site 0134) Warrenville, Illinois, United States
  • University of Iowa ( Site 0104) Iowa City, Iowa, United States
View all 84 locations
View Trial Details
Recruiting

Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.

NCT07165132

Conditions
Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +24 more
Locations
  • Research Facility Iowa City, Iowa, United States
  • Research Facility Lexington, Kentucky, United States
  • Research Facility St Louis, Missouri, United States
  • Research Facility St Louis, Missouri, United States
View Trial Details
Recruiting

A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism

NCT06881992

Conditions
Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +29 more
Locations
  • Investigative Site Chicago, Illinois, United States
  • Investigative Site Bethesda, Maryland, United States
  • Investigative Site Boston, Massachusetts, United States
  • Investigative Site Rochester, Minnesota, United States
View all 13 locations
View Trial Details
Recruiting

Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors

NCT05687123

Conditions
Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +14 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • Memorial Hospital East Shiloh, Illinois, United States
View Trial Details
Recruiting

Nutrition Intervention for Pancreatic Cancer

NCT07554560

Conditions
Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +12 more
Locations
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • University of Pennsylvania Abramson Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details
Recruiting

Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy

NCT05477576

Conditions
Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +22 more
Locations
  • Research Facility Phoenix, Arizona, United States
  • Research Facility Duarte, California, United States
  • Research Facility Irvine, California, United States
  • Research Facility Los Angeles, California, United States
View all 54 locations
View Trial Details

Related conditions